Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

BACKGROUND: Growth impairment remains common in children with chronic kidney disease (CKD). Available literature indicates low level of recombinant human growth hormone (rhGH) utilization in short children with CKD. Despite efforts at consensus guidelines, lack of high-level evidence continues to co...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Nephrol
Autori principali: Akchurin, Oleh M., Kogon, Amy J., Kumar, Juhi, Sethna, Christine B., Hammad, Hoda T., Christos, Paul J., Mahan, John D., Greenbaum, Larry A., Woroniecki, Robert
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450116/
https://ncbi.nlm.nih.gov/pubmed/28558814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0599-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi